Global Preclinical Assets Market: Key Developments
In September 2021, Viroclinics-DDL, a global contract research organization, announced the launch of Viroclinics Xellerate, a newly formed Business Unit focused on clinical trial support and global logistics services.
On February 17, 2022, Viroclinics-DDL, a global contract research organization, announced that Cerba Research, the group’s global clinical trial central and specialty laboratory services division, had merged with Viroclinics-DDL, a global specialist virology and immunology contract research organization (CRO). This merger will help the company in further expanding and transforming diagnostic solutions for clinical trials
In November 2019, Envigo RMS LLC, a global supplier of research models and associated services, announced an agreement to acquire the assets of the research models business unit of Horizon Discovery Group plc., a research company. This acquisition will help the company in further expansion of the services in clinical research.
Preclinical Assets Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients